Obesity
|
0.400 |
Biomarker
|
disease |
RGD |
The expression of adiponutrin mRNA is also 50-fold elevated in genetically obese fa/fa rats, indicating a link between adiponutrin and obesity.
|
11431482 |
2001 |
Hyperinsulinism
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
The mRNA level was negatively correlated with fasting glucose (Rho = -0.62; P < 0.0001), and subjects with high adiponutrin mRNA level had an increased insulin sensitivity.
|
15181042 |
2004 |
liposarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Quantitative PCR revealed dramatically increased expression of iPLA2epsilon and iPLA2zeta transcripts during the hormone-induced differentiation of 3T3-L1 cells into adipocytes and identified the presence of all three iPLA2 isoforms in human SW872 liposarcoma cells.
|
15364929 |
2004 |
Adult Liposarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Quantitative PCR revealed dramatically increased expression of iPLA2epsilon and iPLA2zeta transcripts during the hormone-induced differentiation of 3T3-L1 cells into adipocytes and identified the presence of all three iPLA2 isoforms in human SW872 liposarcoma cells.
|
15364929 |
2004 |
Childhood Liposarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Quantitative PCR revealed dramatically increased expression of iPLA2epsilon and iPLA2zeta transcripts during the hormone-induced differentiation of 3T3-L1 cells into adipocytes and identified the presence of all three iPLA2 isoforms in human SW872 liposarcoma cells.
|
15364929 |
2004 |
Hyperglycemia
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
In a pathological context, adiponutrin gene was highly expressed in the adipose tissue of type-1 diabetic patients with chronic hyperglycemia compared with healthy subjects.
|
16914601 |
2006 |
Non-alcoholic Fatty Liver Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Thus, variation in PNPLA3 contributes to ancestry-related and inter-individual differences in hepatic fat content and susceptibility to NAFLD.
|
18820647 |
2008 |
Non-alcoholic Fatty Liver Disease
|
0.500 |
Biomarker
|
disease |
CTD_human |
Thus, variation in PNPLA3 contributes to ancestry-related and inter-individual differences in hepatic fat content and susceptibility to NAFLD.
|
18820647 |
2008 |
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
|
18820647 |
2008 |
Nonalcoholic Steatohepatitis
|
0.500 |
Biomarker
|
disease |
CTD_human |
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
|
18820647 |
2008 |
Fatty Liver
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
|
18820647 |
2008 |
Obesity
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This study aimed to replicate the association between PNPLA3 variants and obesity, and to investigate their effect on insulin resistance and beta-cell function.
|
18728122 |
2008 |
Alanine aminotransferase measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.
|
18940312 |
2008 |
Measurement of liver enzyme
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.
|
18940312 |
2008 |
Finding of liver enzyme levels
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.
|
18940312 |
2008 |
Serum Alanine Aminotransferase Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.
|
18940312 |
2008 |
Hyperinsulinism
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity.
|
18728122 |
2008 |
Non-alcoholic Fatty Liver Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.
|
19738004 |
2009 |
Non-alcoholic Fatty Liver Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Our aims were to develop a method to accurately predict non-alcoholic fatty liver disease (NAFLD) and liver fat content based on routinely available clinical and laboratory data and to test whether knowledge of the recently discovered genetic variant in the PNPLA3 gene (rs738409) increases accuracy of the prediction.
|
19524579 |
2009 |
Steatohepatitis
|
0.500 |
Biomarker
|
disease |
BEFREE |
PNPLA3 may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences.
|
19651814 |
2009 |
Steatohepatitis
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A common variant in PNPLA3 increases the risk of hepatic steatosis in humans.
|
19224197 |
2009 |
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.
|
19224197 |
2009 |
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.
|
19738004 |
2009 |
Fatty Liver
|
0.400 |
Biomarker
|
disease |
BEFREE |
PNPLA3 may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences.
|
19651814 |
2009 |
Fatty Liver
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A common variant in PNPLA3 increases the risk of hepatic steatosis in humans.
|
19224197 |
2009 |